The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

University of Vermont

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01341171

V0805

Details and patient eligibility

About

Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.

Enrollment: 30 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women routinely taking tamoxifen or aromatase inhibitor therapy as prescribed by their oncologist

Exclusion criteria

• Use of heparin, warfarin

Trial design

30 participants in 1 patient group

tamoxifen or aromatase inhibitors